The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study

• Published in: Diabetology international Vol. 13; no. 1; pp. 85 - 90
• Main Authors: Hosomi, Yukako, Munekawa, Chihiro, Hashimoto, Yoshitaka, Okamura, Takuro, Takahashi, Fuyuko, Kawano, Rena, Nakajima, Hanako, Majima, Saori, Senmaru, Takafumi, Nakanishi, Naoko, Ushigome, Emi, Hamaguchi, Masahide, Yamazaki, Masahiro, Fukui, Michiaki
• Format: Journal Article
• Language: English
• Published: Singapore Springer Singapore 01.01.2022; Springer Nature B.V
• Subjects: Acute effects; Body weight; Cohort analysis; Coronaviruses; COVID-19; Diabetes; Diabetes mellitus (insulin dependent); Endocrinology; Food intake; Hemoglobin; Lifestyles; Medicine; Medicine & Public Health; Metabolic Diseases; Original; Original Article; Pandemics; Patients; Questionnaires; Sleep; COVID-19; Infection; Lifestyle; Type 1 diabetes; Stress
• DOI: 10.1007/s13340-021-00507-4
• ISSN: 2190-1678

Background To investigate the acute effects of coronavirus disease (COVID-19) on lifestyle and metabolic parameters in patients with type 1 diabetes (T1D). Methods This retrospective cohort study included 34 patients who were admitted to our hospital from April 16 to May 1, 2020. Data on stress levels, sleep duration, exercise, total diet, snacks, and prepared food intake were obtained from the questionnaires. Changes in the values of hemoglobin A1c (HbA1c) and body weight from 3 months before the administration of the questionnaire to the time the study questionnaire was administered (pandemic year), and those from 15 months before to 12 months before the administration of the questionnaire (pre-pandemic year) were evaluated. Results Increased stress levels and decreased exercise volumes were observed in approximately 60% and 50% of participants during the COVID-19 pandemic, respectively. Decreased sleep duration was associated with changes in the body weight for 3 months during pandemic year ( r  = − 0.40, p  = 0.043). Furthermore, compared with changes in HbA1c for 3 months during pre-pandemic year, changes in HbA1c during the pandemic year were worse (0.12% [0.33] % during pandemic year vs. − 0.09 [0.39] % during pre-pandemic year, p  = 0.027). Conclusions Many patients experienced stress and exercised less due to the COVID-19 pandemic. Glycemic control in patients with T1D was worse than that in the previous year. Since the pandemic is currently ongoing, more attention should be paid to stress and lifestyle factor management in patients with T1D.